Herr HW, Sogani PC. Does early cystectomy improve the survival of. J. Urol 2001; 166 :1296
Sogani PC, Perrotti M. Herr HW, Fair WR, Thaler HT, Bosl G. Clinical Stage I Testis Cancer: Long Term Outcome of Patients on Surveillance. J. Urol 1998; 159 :855
Herr HW, Cookson MS, Zhang ZF, Soloway S, Sogani PC, Fair WR. The treated natural history of high-risk superficial bladder cancer. J. Urol 1997; 158 :62
Fair WR, Cookson MS, Stroumbakis N. Cohen D, Aprikian AG, Wang Y. The Indications, Rationale and Results of Neoadjuvant Androgen Deprivation in the Treatment of Prostate Cancer. Memorial Sloan-Kettering Cancer Center results. Urology 1997; 49 :46
Herr HW, Schwalb DM, Zhang ZF, Sogani PC, Fair WR, Whitmore WF, Oettgen HF. Intravesical Bacillus Calmette-Guerin Therapy Prevents Tumor Progression and Death from Superficial Bladder Cancer: Ten-year follow-up of a prospective randomized trial. J Clin Oncol 1995; 13 :1404
Aprikian AG, Fair WF, Reuter VE, Sogani PC, Herr HW, Russo P, Sheinfeld J. Experience with Neoadjuvant DES and Radical Prostatectomy in Patients with Locally Advanced Prostate Cancer. Br J Urol 1994; 74 :630
Vieweg J, Whitmore WF, Herr HW, Sogani PC, Russo P, Sheinfeld J, Fair WR. The Role of Pelvic Lymphadenopathy and Radical Cystectomy in Node-Positive Bladder Cancer: The MSKCC Experience. Cancer 1994; 73 :3020
Schwalb M, Herr HW, Sogani PC, Russo P, Sheinfeld J, Fair WR. Positive Urine Cytology Following a Complete Response to Intravesicle BCG Therapy: Pattern of Recurrence. J Urol 1994; 152 :382
Fair WR, Aprikian A, Sogani PC, Reuter V, Whitmore WF. Role of Neoadjuvant Hormonal Manipulation in Localized Prostate Cancer. Cancer 1993; 71 :1031
Davis BE, Sogani PC, Herr HW. Association of Primary Germ-Cell Tumor of the Testis and Renal Cell Carcinoma. J Urol 1993; 150 :1489
Return to Pramod C. Sogani, MD, FACS Main Page.
